Controversies of Progress: The Human Genome Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Controversies of Progress: The Human Genome case study

At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Controversies of Progress: The Human Genome case study is a Harvard Business School (HBR) case study written by R. Edward Freeman, Pia Ahmad, Bidhan Parmar, Will Truslow. The Controversies of Progress: The Human Genome (referred as “Genome Controversies” from here on) case study provides evaluation & decision scenario in field of Organizational Development. It also touches upon business topics such as - Value proposition, Ethics, Health, Social responsibility.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment

---

Case Description of Controversies of Progress: The Human Genome Case Study

The case lays out the controversies surrounding the human genome project. The ability to generate any individual's genetic profile raises important legal, social, and ethical questions. How should these issues be addressed and how can the rights of the individual be protected? This case can be used to portray problems in the biotechnology industry, confidentiality in the health care industry, as well as the progress of technology and the ability of the present legal and medical system to deal with it.

Case Authors : R. Edward Freeman, Pia Ahmad, Bidhan Parmar, Will Truslow

Topic : Organizational Development

Related Areas : Ethics, Health, Social responsibility

---

Calculating Net Present Value (NPV) at 6% for Controversies of Progress: The Human Genome Case Study

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 6 %	Discounted Cash Flows
Year 0	(10029769)	-10029769	-	-
Year 1	3458297	-6571472	3458297	0.9434	3262544
Year 2	3964032	-2607440	7422329	0.89	3527974
Year 3	3971151	1363711	11393480	0.8396	3334255
Year 4	3245470	4609181	14638950	0.7921	2570716
TOTAL			14638950		12695490

The Net Present Value at 6% discount rate is 2665721

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting

What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.

---

Capital Budgeting Approaches

Methods of Capital Budgeting

There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Profitability Index
2. Net Present Value
3. Payback Period
4. Internal Rate of Return

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Genome Controversies have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Genome Controversies shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.

---

Formula and Steps to Calculate Net Present Value (NPV) of Controversies of Progress: The Human Genome

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Organizational Development Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Genome Controversies often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Genome Controversies needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 15 %	Discounted Cash Flows
Year 0	(10029769)	-10029769	-	-
Year 1	3458297	-6571472	3458297	0.8696	3007215
Year 2	3964032	-2607440	7422329	0.7561	2997378
Year 3	3971151	1363711	11393480	0.6575	2611096
Year 4	3245470	4609181	14638950	0.5718	1855608
TOTAL					10471297

The Net NPV after 4 years is 441528

(10471297 - 10029769 )

---

Calculating Net Present Value (NPV) at 20%

If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 20 %	Discounted Cash Flows
Year 0	(10029769)	-10029769	-	-
Year 1	3458297	-6571472	3458297	0.8333	2881914
Year 2	3964032	-2607440	7422329	0.6944	2752800
Year 3	3971151	1363711	11393480	0.5787	2298120
Year 4	3245470	4609181	14638950	0.4823	1565138
TOTAL					9497972

The Net NPV after 4 years is -531797

At 20% discount rate the NPV is negative (9497972 - 10029769 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Genome Controversies to discount cash flow at lower discount rates such as 15%.

Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Genome Controversies has a NPV value higher than Zero then finance managers at Genome Controversies can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Genome Controversies, then the stock price of the Genome Controversies should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Genome Controversies should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What will be a multi year spillover effect of various taxation regulations.

What can impact the cash flow of the project.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.

---

Negotiation Strategy of Controversies of Progress: The Human Genome

References & Further Readings

R. Edward Freeman, Pia Ahmad, Bidhan Parmar, Will Truslow (2018), "Controversies of Progress: The Human Genome Harvard Business Review Case Study. Published by HBR Publications.